Amtech Systems vs Trio-Tech International
ASYS and TRT side by side, both in special industry machinery, except metalworking. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ASYS and TRT compare
Amtech Systems is the larger company, worth 3.8 times as much as Trio-Tech International ($211M against $55.7M).
Trio-Tech International grew revenue faster over the last twelve months (71.6% versus −2.4% for Amtech Systems).
Amtech Systems keeps more of each dollar of sales as profit, with a net margin of 4.9% compared with −0.05% at Trio-Tech International.
Amtech Systems scores higher on the StockData Score (11 against 8 for Trio-Tech International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ASYS | TRT |
|---|---|---|
| Size and price | ||
| Market cap | $211M | $55.7M |
| Share price | $12.07 | $5.36 |
| Change, 1 year | 59.0% | 61.2% |
| Change, 5 years | 9.4% | 18.5% |
| Beta (5Y) | 1.22 | 0.81 |
| Employees | 264 | 19 |
| StockData Score | ||
| Total score | 11 (better) | 8 |
| Valuation score | 1 | 1 |
| Growth score | 1 | 2 (better) |
| Performance score | 3 (better) | 0 |
| Health score | 6 (better) | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 46.4× | – |
| P/S | 2.6× | 0.9× (better) |
| P/B | 1.8× | 1.2× (better) |
| EV/EBITDA | 14.2× (better) | 15.3× |
| P/FCF | 24.2× (better) | 33.0× |
| FCF yield | 4.1% (better) | 3.0% |
| Fair value | $10.00 | $4.51 |
| Margin of safety | −20.7% | −18.8% (better) |
| Growth | ||
| Revenue growth (TTM) | −2.4% | 71.6% (better) |
| Revenue growth, 5Y average | 3.9% | 14.0% (better) |
| Profitability | ||
| Gross margin | 46.9% (better) | 16.6% |
| Operating margin | 8.1% (better) | −0.33% |
| Net margin | 4.9% (better) | −0.05% |
| FCF margin | 10.7% (better) | 2.7% |
| Return on equity | 4.8% (better) | −0.09% |
| Return on invested capital | 11.8% (better) | −0.44% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | 265× (better) | −3.1× |
| Current ratio | 5.41 (better) | 3.44 |
| Altman Z-score | 3.89 (better) | 3.80 |
| Piotroski F-score | 2 | 5 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 0.02% |
| Shareholder yield | 0.00% | 0.02% (better) |
| Ownership | ||
| Held by institutions | 64.6% | 21.1% |
| Held by insiders | 18.7% | 29.8% |
| Insider net buying, 12 months | $77.8K (better) | −$3.0M |
| Short interest, % of float | 10.1% | 9.9% |
Go deeper
- ASYS stock overview
- ASYS income statement
- ASYS valuation and score
- TRT stock overview
- TRT income statement
- TRT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.